Pangaea Oncology Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	14.35	9.95	6.68	6.71	6.18	5.5
Revenue Growth (YoY)	122.29%	49.12%	-0.48%	8.61%	12.20%	-3.10%
Cost of Revenue	2.58	2.4	2.73	1.65	1.63	1.1
Gross Profit	11.77	7.56	3.94	5.05	4.55	4.41
Selling, General & Admin	13.24	9.35	5.35	4.41	3.95	3.92
Other Operating Expenses	0.06	-0.16	0.04	0.29	0.07	0.04
Operating Expenses	15.72	11	6.64	5.7	6.43	7.04
Operating Income	-3.95	-3.44	-2.7	-0.64	-1.88	-2.63
Interest Expense	-0.29	-0.13	-0.19	-0.25	-0.19	-0.19
Interest & Investment Income	-	0.12	0.02	0	-	-
Earnings From Equity Investments	-0.01	-0.06	-0.16	-0.19	-0.04	-
Currency Exchange Gain (Loss)	-0.01	-0.01	0	-0.01	-0.02	-0
Other Non Operating Income (Expenses)	0.11	0.13	0.14	0.09	0.26	0.34
EBT Excluding Unusual Items	-4.15	-3.39	-2.88	-1.01	-1.86	-2.49
Impairment of Goodwill	-0.51	-0.51	-	-	-	-
Gain (Loss) on Sale of Investments	0.39	0.39	0.04	-0.09	-	-
Asset Writedown	0	-	-	-	-	-2.5
Pretax Income	-4.27	-3.51	-2.84	-1.1	-1.86	-4.98
Income Tax Expense	1.24	1.29	-0.11	-0.46	-0.11	-0.14
Earnings From Continuing Operations	-5.51	-4.79	-2.72	-0.64	-1.75	-4.84
Minority Interest in Earnings	0.19	0.14	0.01	-	-	-
Net Income	-5.34	-4.66	-2.71	-0.64	-1.75	-4.84
Net Income to Common	-5.34	-4.66	-2.71	-0.64	-1.75	-4.84
Shares Outstanding (Basic)	30	30	30	23	19	17
Shares Outstanding (Diluted)	30	30	30	23	19	17
Shares Change (YoY)	3.35%	-0.98%	35.11%	20.34%	10.89%	28.80%
EPS (Basic)	-0.18	-0.15	-0.09	-0.03	-0.09	-0.29
EPS (Diluted)	-0.18	-0.15	-0.09	-0.03	-0.09	-0.29
Free Cash Flow	-2.9	-2.65	-3.7	-2.53	-1.99	-2.4
Free Cash Flow Per Share	-0.10	-0.09	-0.12	-0.11	-0.11	-0.14
Gross Margin	82.01%	75.92%	59.06%	75.36%	73.63%	80.08%
Operating Margin	-27.52%	-34.59%	-40.40%	-9.56%	-30.51%	-47.86%
Profit Margin	-37.18%	-46.77%	-40.63%	-9.57%	-28.37%	-87.93%
Free Cash Flow Margin	-20.19%	-26.66%	-55.36%	-37.67%	-32.16%	-43.56%
EBITDA	-3.26	-2.69	-2.31	-0.27	-1.51	-2.2
EBITDA Margin	-22.70%	-27.07%	-34.62%	-4.02%	-24.38%	-39.92%
D&A For EBITDA	0.69	0.75	0.39	0.37	0.38	0.44
EBIT	-3.95	-3.44	-2.7	-0.64	-1.88	-2.63
EBIT Margin	-27.52%	-34.59%	-40.40%	-9.56%	-30.51%	-47.86%
Revenue as Reported	12.26	8	4.37	-	-	-
Advertising Expenses	-	0.18	0.07	0.03	-	-

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.